Where Global Innovation
and Capital Meet

Flotation

Exits: May 26, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

May 26, 2022

Exits: May 24, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

May 24, 2022

Microba makes tracks to ASX

The gut microbiome drug developer went public in a $22.5m offering priced at the foot of its range.

Apr 7, 2022

Exits: February 7, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Feb 7, 2022

Exits: February 1, 2022

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Feb 1, 2022

SenseTime scores $851m in initial public offering

The producer of image recognition technology stemmed from Chinese University of Hong Kong’s Media Lab has gone public in Hong Kong as the Chinese government introduces new regulations governing foreign IPOs.

Dec 31, 2021

Exits: November 26, 2021

A roundup of exits, including IPOs and acquisitions, across the tech transfer ecosystem.

Nov 26, 2021

Blade to get a slice of Nasdaq action

Johns Hopkins spinout Blade Therapeutics has agreed to a reverse merger that will net it $24.3m in Pipe financing from backers including Osage University Partners.

Nov 11, 2021

Other News

Entrada Therapeutics enters Nasdaq

The Ohio State spinout has gone public in an upsized IPO sized at approximately $182m.

Nov 11, 2021

Pyxis progresses to stock market

Having priced its shares at the top of its range, UChicago spinout Pyxis Oncology suffered a drop on the first day of trading.

Oct 11, 2021

Exscientia expands IPO to over $350m

The cancer drug developer has closed its initial public offering after underwriters exercised the greenshoe option.

Oct 7, 2021

Pyxis picks price range

UChicago spinout Pyxis Oncology is aiming to raise more than $153m in its initial public offering, having set a price range of $14 to $16.

Oct 5, 2021

Exscientia establishes Nasdaq listing

The Dundee spinout has raised more than $304m in its IPO in the US, with another $160m secured through a concurrent private placement.

Oct 4, 2021

Editor's Picks

The Big Deal: Acrivon gives the IPO market a boost

The cancer drug developer popped after an upsized offering, allowing Alexandria Venture Investments to exit and showing the IPO market is still breathing in the US.

Nov 18, 2022

The Standout Six: The deals you need to know about this week

Healthcare companies may be driving a public markets recovery while Lunar Energy, helmed by Tesla's former head of energy, has emerged from stealth with $300m.

Aug 26, 2022

GoTo gets $1.1bn in initial public offering

The multicorporate-backed diversified mobile app operator has listed on IDX having priced its shares at near the top of their range.

Mar 29, 2022

Braze breaches public markets in $520m IPO

Citi Ventures-backed Braze priced the offering above its range and it valued the customer engagement software producer at almost $5.9bn.

Nov 18, 2021
© 2024 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here